NCAM1 and lymphopenia: Lymphopenia occurred in all patients (grade 3/4 in 46 patients [96%]), with all evaluated lymphocyte subsets (CD3+, CD4+, CD8+, CD16+, CD20+, CD56+) showing reductions from baseline (Fig. 2).